scholarly article | Q13442814 |
P2093 | author name string | P. de Saussure | |
J. J. Widmann | |||
L. Perrin | |||
J. A. Schifferli | |||
E. Giostra | |||
A. Pechère-Bertschi | |||
P2860 | cites work | Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia | Q27473547 |
The 5'-terminal sequence of the hepatitis C virus genome. | Q33943535 | ||
Biologic and clinical significance of cryoglobulins. A report of 86 cases | Q34204386 | ||
Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis | Q37821429 | ||
Clearance of cryoglobulins in man. | Q39487492 | ||
Reappraisal of the clinical expression of mixed cryoglobulinemia | Q39519978 | ||
Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: false positive results are related to hyper-gamma-globulinaemia | Q42981094 | ||
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia | Q42984959 | ||
Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. | Q42985058 | ||
Mixed cryoglobulinemia in hepatitis C virus infection. Value of interferon therapy | Q43420646 | ||
Cutaneous vasculitis and cryoglobulinaemia type II associated with hepatitis C virus infection | Q44839615 | ||
Cryoglobulinemia and liver involvement. | Q45191264 | ||
Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. | Q45791425 | ||
Hepatitis B virus and essential mixed cryoglobulinaemia. | Q45806713 | ||
Correlation of hepatocyte HBsAg expression with virus replication and liver pathology | Q45832015 | ||
Persistent Epstein-Barr virus infection in patients with type II essential mixed cryoglobulinemia | Q45841525 | ||
Hepatitis C virus in patients with cryoglobulinemia type II. | Q45852251 | ||
Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia | Q54282922 | ||
Liver involvement in the syndrome of mixed cryoglobulinemia | Q67671002 | ||
Mixed cryoglobulinemia responsive to interferon-alpha | Q68058649 | ||
Treatment of idiopathic mixed cryoglobulinemia with alpha interferon | Q69436993 | ||
Defective immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with mixed essential cryoglobulinemia type II | Q70232485 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis C | Q154869 |
P304 | page(s) | 419-22 | |
P577 | publication date | 1992-09-01 | |
P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
P1476 | title | Hepatitis C: a possible etiology for cryoglobulinaemia type II | |
P478 | volume | 89 |
Q43039898 | Absence of hepatitis B and C viruses in pediatric idiopathic membranoproliferative glomerulonephritis |
Q27473447 | Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia |
Q42206660 | Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites |
Q50588813 | Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation |
Q36819743 | Bilateral forefoot ischemia as a premonitory symptom of mixed cryoglobulinemia |
Q39628327 | Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus |
Q33811619 | Cryoglobulinemia |
Q35547463 | Cryoglobulins are not essential |
Q45722542 | Cryoglobulins in chronic hepatitis C virus infection |
Q42991870 | Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture |
Q33363781 | Hepatitis C virus-associated extrahepatic manifestations: a review |
Q42984600 | Hepatitis-C-associated cryoglobulinemia after liver transplantation |
Q71181628 | High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? |
Q43036358 | High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia |
Q27473439 | IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia |
Q43503505 | In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus-associated mixed cryoglobulinemia |
Q43039778 | Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis |
Q41519669 | Mixed cryoglobulinemia as a model of systemic vasculitis |
Q41201723 | Mixed cryoglobulinemia secondary to hepatitis C virus infection |
Q33735350 | Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? |
Q42999023 | Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process |
Q36672333 | Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients |
Q71200519 | Red fingers syndrome in patients with HIV and hepatitis C infection |
Q74835670 | Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis |
Q40591268 | Renal manifestations of hepatitis C virus infection |
Q45759948 | Symmetric polyarthritis with livedo reticularis: A newly recognized manifestation of hepatitis C virus infection |
Q44129796 | The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin |
Q27478129 | Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia |
Search more.